Prednisolone

Immunosuppression	13.7%
Product Used For Unknown Indication	9.7%
Renal Transplant	8.8%
Rheumatoid Arthritis	8.4%
Drug Use For Unknown Indication	6.5%
Systemic Lupus Erythematosus	5.6%
Prostate Cancer	5.4%
Prostate Cancer Metastatic	4.9%
Hypertension	4.6%
Prophylaxis	4.0%
Cancer Pain	3.8%
Acute Lymphocytic Leukaemia	3.6%
Diffuse Large B-cell Lymphoma	3.3%
Crohn's Disease	3.2%
Organ Transplant	2.9%
Chemotherapy	2.7%
Non-hodgkin's Lymphoma	2.6%
Immunosuppressant Drug Therapy	2.1%
B-cell Lymphoma	2.0%
Colitis Ulcerative	2.0%

Basal Cell Carcinoma	11.9%
Chorioretinopathy	9.8%
Vomiting	9.0%
Sepsis	7.5%
Pneumonia	5.6%
Weight Decreased	5.3%
Respiratory Failure	4.7%
Tendon Rupture	4.7%
Pyrexia	4.4%
Visual Acuity Reduced	4.4%
Pneumatosis Intestinalis	4.2%
Pneumocystis Jiroveci Pneumonia	4.2%
Renal Impairment	3.5%
Drug Ineffective	3.3%
Weight Increased	3.3%
Urinary Tract Infection	3.0%
Foetal Exposure During Pregnancy	2.9%
Pancytopenia	2.9%
Rhabdomyolysis	2.9%
Thrombocytopenia	2.9%

Secondary

Rheumatoid Arthritis	21.4%
Product Used For Unknown Indication	11.7%
Diffuse Large B-cell Lymphoma	8.0%
Prophylaxis	7.9%
Drug Use For Unknown Indication	6.5%
Renal Transplant	5.8%
Juvenile Arthritis	5.2%
B-cell Lymphoma	3.9%
Hypertension	3.8%
Non-hodgkin's Lymphoma	3.2%
Immunosuppression	3.1%
Juvenile Idiopathic Arthritis	3.0%
Castleman's Disease	2.6%
Osteoporosis	2.4%
Graft Versus Host Disease	2.3%
Acute Lymphocytic Leukaemia	2.1%
Hodgkin's Disease	2.1%
Behcet's Syndrome	1.8%
Adult T-cell Lymphoma/leukaemia	1.6%
Prophylaxis Against Transplant Rejection	1.6%

Pneumocystis Jiroveci Pneumonia	10.4%
Sepsis	8.4%
Pyrexia	7.3%
Pneumonia	6.7%
Urinary Tract Infection	6.3%
Vomiting	6.3%
Renal Impairment	5.3%
Thrombocytopenia	5.0%
White Blood Cell Count Decreased	5.0%
Upper Respiratory Tract Inflammation	4.2%
Respiratory Failure	4.1%
White Blood Cell Count Increased	3.7%
Transplant Rejection	3.6%
Neutropenia	3.6%
Febrile Neutropenia	3.5%
Rheumatoid Arthritis	3.5%
Osteonecrosis	3.4%
Weight Increased	3.3%
Herpes Zoster	3.2%
Tendon Rupture	3.2%

Concomitant

Rheumatoid Arthritis	29.9%
Product Used For Unknown Indication	18.5%
Drug Use For Unknown Indication	14.4%
Prophylaxis	8.0%
Hypertension	4.6%
Osteoporosis	2.6%
Crohn's Disease	2.3%
Colitis Ulcerative	2.3%
Renal Transplant	1.9%
Juvenile Arthritis	1.9%
Asthma	1.8%
Pain	1.6%
Infection Prophylaxis	1.5%
Juvenile Idiopathic Arthritis	1.3%
Diabetes Mellitus	1.3%
Premedication	1.3%
Prophylaxis Against Gastrointestinal Ulcer	1.2%
Insomnia	1.2%
Idiopathic Thrombocytopenic Purpura	1.2%
Constipation	1.2%

Pyrexia	10.1%
Vomiting	9.1%
Pneumonia	8.3%
White Blood Cell Count Decreased	8.1%
Sepsis	6.7%
Interstitial Lung Disease	5.6%
Rash	4.9%
Respiratory Failure	4.9%
Rheumatoid Arthritis	4.4%
Urinary Tract Infection	4.2%
Death	4.0%
Thrombocytopenia	3.9%
Weight Decreased	3.8%
Renal Impairment	3.8%
White Blood Cell Count Increased	3.3%
Liver Disorder	3.2%
Pulmonary Embolism	3.2%
Pneumocystis Jiroveci Pneumonia	3.0%
Malaise	2.9%
Drug Ineffective	2.6%

Interacting

Product Used For Unknown Indication	25.9%
Hypertension	13.6%
Rheumatoid Arthritis	9.4%
Prophylaxis Against Gastrointestinal Ulcer	5.4%
Chronic Obstructive Pulmonary Disease	4.9%
Ewing's Sarcoma	4.9%
Immunosuppression	3.9%
Osteoporosis	3.9%
Pneumonia	3.9%
Cardiac Failure	3.0%
Pulmonary Tuberculosis	2.8%
Asthma	2.7%
Colitis Ulcerative	2.5%
Renal Transplant	2.2%
Type 1 Diabetes Mellitus	2.2%
Antiretroviral Therapy	1.8%
Prophylaxis Against Transplant Rejection	1.8%
Atrial Fibrillation	1.6%
Drug Use For Unknown Indication	1.6%
Urinary Tract Infection	1.6%

Drug Interaction	24.7%
Renal Impairment	7.5%
Tracheobronchitis	7.5%
Myocardial Infarction	6.5%
Respiratory Failure	6.5%
Anaphylactic Reaction	5.4%
Pemphigoid	4.3%
Alanine Aminotransferase Increased	3.2%
Clostridium Difficile Colitis	3.2%
Gastrooesophageal Reflux Disease	3.2%
Haemolytic Uraemic Syndrome	3.2%
Metabolic Alkalosis	3.2%
Myositis	3.2%
Transaminases Increased	3.2%
Transplant Rejection	3.2%
Vomiting	3.2%
Arthralgia	2.2%
Blood Sodium Decreased	2.2%
Diabetic Ketoacidosis	2.2%
Dyspnoea	2.2%